1McQuellon RP,Loggie BW,Fleming RA,et al.Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.Eur J Surg Oncol,2001,27:65-73.
1[3]Los G,Verdegaal EM,Mutsaers PH,et al.Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy.Cancer Chemother Pharmacol,1991,28(3):159-165.
2[4]Dedrick RL,Myers CE,Bungay PM,et al.Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovrian cancer.Cancer treat Rep,1978,62(1):1-11.
3[5]Archer S,Gray B.Intrperitoneal 5-fluorouracil infusion for treatment of both peritoneal and liver micrometastases.Surgery,1990,108(3):502-507.
4[6]Sugarbaker PH,Gianola FJ,Speyer JC,et al.Prospective randomized trial of intravenouse verus intraperitoneal 5-flurouracil in patient with advanced primary colon or rectal cancer.Surgery,1985,98(3):414-422.
5[7]Atigo.A phase Ⅱ trial of adjuvant intravenous and intraperitoneal flurouracil and IP cisplatin in resected gastric cancer.Proc Am Soc Clin Oncol,1990,9:122.
6[10]Yu-W,Whang-I,Suh-I,et al.Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer.Ann-Surg,1998,28(3):347-354.
